Subscribe To

Price Alert Latest News Economic Calendar News

AVCRF / Avricore Health to enhance diabetes care through integration of HealthTab with CONTOUR blood glucose meters

Avricore Health (TSX-V:AVCR, OTC:AVCRF) announced that it has partnered with Ascensia Diabetes Care to integrate its blood glucose monitoring systems with Avricore's pharmacy-based point-of-care testing platform HealthTab. Avricore said the objective of the partnership is to support patients and pharmacists in Canada to better manage diabetes by linking daily blood glucose testing results and pattern history data collected via Ascensia's CONTOUR NEXT GEN or CONTOUR NEXT ONE meters to the patient's HealthTab account. Read More

Demo Live Account See Partner Details

Content Topics

Avricore

Health

Enhance

Diabetes

Care

Through

Integration

Healthtab

Contour

Glucose

Meters

Stock

AVCRF

Posted: Jul 19 2023, 08:58

Author Name: Proactive Investors

AVCRF News

By Proactive Investors
August 30, 2023

Avricore Health sees nothing but blue skies ahead as it scales up point-of-care testing solution HealthTab

Avricore Health (TSX-V:AVCR, OTC:AVCRF) said it in the first half of 2023 it continues to surpass financial targets, strike partnerships, and develop

By Proactive Investors
July 19, 2023

Avricore Health to enhance diabetes care through integration of HealthTab with CONTOUR blood glucose meters

Avricore Health (TSX-V:AVCR, OTC:AVCRF) announced that it has partnered with Ascensia Diabetes Care to integrate its blood glucose monitoring systems

By Proactive Investors
March 23, 2023

Avricore Health expands HealthTab network to more than 530 locations and adds testing for virus detection

Avricore Health (TSX-V:AVCR, OTC:AVCRF) Inc, which is focused on delivering point-of-care testing and data solutions for pharmacies through its turnke

By Proactive Investors
February 21, 2023

Avricore Health named one of the Top 50 performing companies on the TSX Venture Exchange

Avricore Health (TSX-V:AVCR, OTC:AVCRF) Inc was recognized as one of the 2023 Venture 50, the TSX Venture Exchange's list of top-performing companies.

By Proactive Investors
February 1, 2023

Avricore Health hits record unaudited revenue surpassing $2M in 2022; expects strong revenue growth in 2023

Avricore Health (TSX-V:AVCR, OTC:AVCRF) Inc said it has successfully entered the second year of a multi-year growth plan to bring its flagship HealthT

By Proactive Investors
January 20, 2023

Avricore Health is empowering patients to make proactive healthcare decisions with its point-of-care testing platform HealthTab

Imagine being able to access a wealth of data about your health by simply visiting your local pharmacy. If you think this concept sounds familiar, y

By Proactive Investors
December 6, 2022

Avricore Health sees 3Q revenue soar by 662% as it successfully scales its HealthTab network

Avricore Health (TSX-V:AVCR, OTC:AVCRF) Inc posted third quarter results that saw its revenue jump 662% year-over-year as the company successfully sca

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.